Nicolai Tangen
AKO Capital
AKO Capital Portfolio 13F
Nicolai Tangen Holdings Activity
- Portfolio value:
- $1.13B≈ (+$15M≈)
- Previous value:
- $1.11B≈
- # of changes:
- 18
- New positions:
- 0
- Reported for:
- 30 Jun 2017 (Q2)
- Latest filing date:
- 01 Aug 2017
AKO Capital has disclosed a total of 18 changes to the portfolio in the (2017 Q2) SEC report(s): increased the number of shares of 9, decreased the number of shares of 8 and completely sold out 1 position(s).
What stocks did Nicolai Tangen buy in 2017 Q2?
During 2017 Q2 Nicolai Tangen has bought 9 securities out of which top 5 purchases (by % change to portfolio) were (EL) Estee Lauder Companies Inc (added shares +29.30%), (USB) U.S. Bancorp (added shares +29.18%), (PX) LINDE INC/CT (added shares +6.23%), (NKE) Nike Inc (added shares +17.98%) and (CTSH) Cognizant Technology Solutions Corp, CL-A (added shares +31.11%).
In the 2017 Q2 report(s) the following changes have been made to the top investments: (RACE) FERRARI NV (reduced shares -10.96%), (V) Visa Inc, CL-A (reduced shares -6.92%), (EL) Estee Lauder Companies Inc (added shares +29.30%), (ALLE) ALLEGION PLC (reduced shares -18.63%) and (USB) U.S. Bancorp (added shares +29.18%).
18 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Cognizant Technology Solutions Corp, CL-A
|
+31.11%
|
$66.40
|
-15.48%($56.12)
|
4.20%
|
2016 Q4
|
≈ 0.75 years
|
||||
|
|
Estee Lauder Companies Inc
|
+29.30%
|
$95.98
|
-8.55%($87.77)
|
5.79%
|
2016 Q4
|
≈ 0.75 years
|
||||
|
|
U.S. Bancorp
|
+29.18%
|
$51.92
|
+24.18%($64.48)
|
4.63%
|
2016 Q4
|
≈ 0.75 years
|
||||
|
|
Nike Inc
|
+17.98%
|
$59.00
|
-29.15%($41.80)
|
4.47%
|
2016 Q4
|
≈ 0.75 years
|
||||
|
|
Alphabet Inc, CL-C
|
+6.80%
|
$45.44
|
+689.44%($358.69)
|
4.16%
|
2016 Q4
|
≈ 0.75 years
|
||||
|
|
LINDE INC/CT
|
+6.23%
|
$132.55
|
|
4.54%
|
2016 Q4
|
≈ 0.75 years
|
||||
|
|
Grifols SA ADR
|
+5.71%
|
$0.76
|
+953.68%($7.97)
|
0.83%
|
2017 Q1
|
≈ 0.50 years
|
||||
|
|
Core Laboratories NV
|
+2.87%
|
$101.27
|
-89.19%($10.95)
|
2.79%
|
2016 Q4
|
≈ 0.75 years
|
||||
|
|
Moodys Corp
|
+1.57%
|
$121.68
|
+298.75%($485.20)
|
3.75%
|
2016 Q4
|
≈ 0.75 years
|
||||
|
|
Colgate-Palmolive Company
|
-0.63%
|
$74.13
|
+26.05%($93.44)
|
3.31%
|
2016 Q4
|
≈ 0.75 years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.